Page 1

ASX Announcement Monday , 17 August 2026 ACL FY26 FINANCIAL RESULTS The following announcements to the market are attached : ✓ Appendix 4E ✓ FY26 financial statements and statutory reports FY26 financial results investor presentation AUSTRALIAN Clinicalabs Australian Clinical Labs Limited ABN 94 645 711 128 Registered Office : 1868-1892 Dandenong Road Clayton VIC 3168 Australia clinicallabs.com.au - ENDS - This announcement was authorised for release to ASX by the Board of ACL . For further information regarding this announcement , please contact : Investor Relations Matthew Cordingley Chief Financial Officer Email : matthew.cordingley@clinicallabs.com.au Phone : +61 ( 0 ) 409 287 681 Governance Eleanor Padman Company Secretary Email : epadman@padmanadvisory.com.au Phone : +61 ( 0 ) 422 002 918 Page 1 of 1 Australian Clinical Labs Limited ABN 94 645 711 128